Forvia (FRVIA) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Dec, 2025Executive summary
Q1 2025 sales reached €6.702 billion, up 2.6% year-over-year (2.1% organic), outperforming global auto production by 80bps despite an unfavorable geographic mix.
Growth was driven by strong performance in Electronics and Seating, with Electronics accounting for nearly 40% of Q1 business awards and robust momentum in China, especially with BYD and Chery.
Confirmed 2025 guidance for sales, operating margin, and net cash flow, maintaining targets despite a revised global vehicle production outlook and ongoing tariff risks.
Ongoing transformation focuses on operational excellence, cost savings, and a core portfolio, with asset disposals and restructuring progressing.
Financial highlights
Q1 2025 sales reached €6.702 billion, up from €6.531 billion in Q1 2024, with 2.1% organic growth and 0.5% positive FX impact.
Electronics posted 12.2% organic growth, with double-digit gains in all major regions; Seating grew 8.2% organically, driven by new launches and a rebound with BYD.
Interiors saw net growth but was penalized by high prior-year tooling sales; Clean Mobility declined 7.4% organically, especially in Europe.
Europe outperformed the market by over 10%, while China sales grew 2.6% organically, with local OEMs now over half of sales in the country.
Outlook and guidance
2025 full-year guidance confirmed: sales between €26.3bn and €27.5bn, operating margin 5.2%-6.0%, net cash flow at least €655 million, and net debt/Adjusted EBITDA ≤1.8x by year-end.
Targeting net debt/Adjusted EBITDA below 1.5x in 2026, supported by asset disposals.
Guidance based on S&P's revised 2025 production forecast, enacted tariffs, and constant exchange rates, assuming no major disruptions.
Latest events from Forvia
- 2024 outlook cut; accelerated cost and China growth actions target stronger 2025 results.FRVIA
Guidance10 Mar 2026 - Margin gains, strong cash flow, and portfolio reshaping set the stage for future growth.FRVIA
Q4 2025 & CMD24 Feb 2026 - Operating margin and cash flow rose, guidance confirmed despite SYMBIO-related net loss.FRVIA
Q2 20253 Feb 2026 - 2.7% organic sales growth, margin gains, and deleveraging progress marked H1 2024.FRVIA
Q2 20243 Feb 2026 - Q3 sales outperformed the market by 420bps, with strong order intake and margin focus.FRVIA
Q3 202419 Jan 2026 - Resilient 2024 results, strong cash flow, and further deleveraging targeted for 2025.FRVIA
Q4 202418 Dec 2025 - Resilient results, new CEO, and strategic focus on sustainability and deleveraging highlighted.FRVIA
AGM 202520 Nov 2025 - Stable Q3 sales and strong cost discipline support confirmed 2025 guidance amid mixed segment trends.FRVIA
Q3 202520 Oct 2025